| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/18/2003 | US20030232372 Method for pheromone discovery in insects |
| 12/18/2003 | US20030232369 Useful in structural homology deduction, in developing and screening agents that affect the activity of eukaryotic RNA polymerase, and in designing modified forms of eukaryotic RNA polymerase |
| 12/18/2003 | US20030232368 Method for detecting a molecular recognition by electrochemiluminescence |
| 12/18/2003 | US20030232364 Gene expression profiling of plasma cells from normal individual and patients with multiple myeloma and monoclonal gammopathy of undetermined significance |
| 12/18/2003 | US20030232358 Identifying the genetic factors responsible for cell differentiation based on expression cloning |
| 12/18/2003 | US20030232356 Skin cell biomarkers and methods for identifying biomarkers using nucleic acid microarrays |
| 12/18/2003 | US20030232354 Use of electron transfer moieties with different redox potentials to electronically detect nucleic acids, such as sequencing of DNA |
| 12/18/2003 | US20030232352 Administering to an indivisual at risk of developing atherosclerosis, a lipopolysaccharide that modulates the function of TLR4 (Toll-Like Receptor 4) sufficient to effect the treatement of atherosclerosis |
| 12/18/2003 | US20030232350 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer |
| 12/18/2003 | US20030232349 Nucleic acid and amino acid sequences of proteases and the use of these sequences in the diagnosis and treatment of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, and neurological disorders |
| 12/18/2003 | US20030232345 Biomolecule resistant surfaces and their methods of use in assays |
| 12/18/2003 | US20030232340 Nanoporous particle with a retained target |
| 12/18/2003 | US20030232335 Minicell-based screening for compounds and proteins that modulate the activity of signalling proteins |
| 12/18/2003 | US20030232334 Novel compositions and methods for cancer |
| 12/18/2003 | US20030232330 Detection and identification of enteric bacteria |
| 12/18/2003 | US20030232326 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
| 12/18/2003 | US20030232325 Contacting a host cell protein or a peptide containing a WW domain with a viral protein or peptide with an amino acid sequence corresponding to the site that binds to WW doamin, to permit binding and forming complex in presence of sample |
| 12/18/2003 | US20030232323 Identifying an agents which inhibit the interaction between a PD-1 ligand and a PD-1 polypeptide, from test agents, determining whether interaction is inhibited, and such agent unable to inhibit interaction, modulates immune response |
| 12/18/2003 | US20030232322 Nitrate sensor |
| 12/18/2003 | US20030232321 Useful for colorimetric detection of glucose in whole blood |
| 12/18/2003 | US20030232074 For stimulating immune activation; for screening immunostimulatory compounds |
| 12/18/2003 | US20030232061 For therapy of respiratory tract infection in a mammal |
| 12/18/2003 | US20030232014 Mass spectrometry-based procedure for detection of amino acid modifications, such as phosphorylation; drug discovery |
| 12/18/2003 | US20030232013 Bringing cancer cell into contact with a peptide-agent complex, wherein peptide comprises an heat stable enterotoxin (ST) motif that binds to breast cancer cells, prostate cancer cells, pancreatic cancer cells or melanoma cancer cells |
| 12/18/2003 | US20030232008 Oxazolidinone photoaffinity probes |
| 12/18/2003 | US20030231987 Devices and methods for performing array based assays |
| 12/18/2003 | US20030231986 Micro-array receiver including a substrate and a first set of sites of a first biological probe, which is adapted to interact with first biological target sample, formed on the substrate, and an identifier to detect first biological probe |
| 12/18/2003 | US20030231985 Form in place gaskets for assays |
| 12/18/2003 | US20030231984 Method to rapidly prepare and screen formulations and compositions containing same |
| 12/18/2003 | US20030231791 Automated system for combining bright field and fluorescent microscopy |
| 12/18/2003 | US20030231552 Wristwatch with measuring function |
| 12/18/2003 | US20030231309 Spectroscopic diagnostic methods and system |
| 12/18/2003 | US20030231304 Metal coated nanocrystalline silicon as an active surface enhanced raman spectroscopy (SERS) substrate |
| 12/18/2003 | DE20212149U1 Vorrichtung zur Untersuchung von Eigenschaften der globalen, insbesondere der primären Hämostasefunktionen An apparatus for investigating properties of global, in particular primary Hämostasefunktionen |
| 12/18/2003 | DE10239616C1 Monitor, for testing for oil in water, has white light through monitor chamber for detection by direct/scattered light sensors sensitive to blue/red, with signal processing to give value independent of emulsion level |
| 12/18/2003 | CA2590618A1 Method of treating cancer using kinase inhibitors |
| 12/18/2003 | CA2527498A1 Total organic carbon (toc) analyzer |
| 12/18/2003 | CA2493890A1 Methods for using adamts-12, an integrin and metalloprotease with thrombospondin motifs |
| 12/18/2003 | CA2489180A1 Method for mapping and eliminating t-cell epitopes |
| 12/18/2003 | CA2489177A1 A disposable cartridge for characterizing particles suspended in a liquid |
| 12/18/2003 | CA2489176A1 Lysing reagent, cartridge and automatic electronic cell counter for simultaneous enumeration of different types of white blood cells |
| 12/18/2003 | CA2489117A1 Measurement of melanocortin peptides and uses thereof |
| 12/18/2003 | CA2489083A1 Method for identifying agonists or antagonists for the g-protein coupled mas-like 1 receptor |
| 12/18/2003 | CA2489053A1 Chromoprotein |
| 12/18/2003 | CA2488939A1 A method of and apparatus for screening to identify drug candidates |
| 12/18/2003 | CA2488932A1 Transgenic mammals expressing polyglutamine |
| 12/18/2003 | CA2488883A1 Method for identifying agonists or antagonists for the gpr45-like/gpr63 receptor |
| 12/18/2003 | CA2488632A1 Type i interferon-inducible proteins to detect viral infection |
| 12/18/2003 | CA2488532A1 Method using a nonlinear optical technique for detection of interactions involving a conformational change |
| 12/18/2003 | CA2488425A1 Methods of regulating differentiation in stem cells |
| 12/18/2003 | CA2488413A1 Eef1a2 for use in the prognosis, diagnosis and treatment of cancer |
| 12/18/2003 | CA2488392A1 Method for analysing a working fluid using impedance spectroscopy |
| 12/18/2003 | CA2488237A1 A biochip kit comprising a biochip based on antigen-antibody reactions, and its usage |
| 12/18/2003 | CA2488227A1 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| 12/18/2003 | CA2487983A1 Method of treating cancer using kinase inhibitors |
| 12/18/2003 | CA2487943A1 Methods of diagnosing & treating diabetes and insulin resistance |
| 12/18/2003 | CA2487924A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
| 12/18/2003 | CA2487438A1 Methods of treating and diagnosing diabetes with cx3cr1 modulators |
| 12/18/2003 | CA2487428A1 Cd200-receptor mediated modulation of bone development |
| 12/18/2003 | CA2487416A1 Methods and compositions for treating and diagnosing diabetes |
| 12/18/2003 | CA2487077A1 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof |
| 12/18/2003 | CA2485709A1 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor |
| 12/18/2003 | CA2480619A1 Novel oxidase |
| 12/17/2003 | EP1371990A1 Microchip |
| 12/17/2003 | EP1371988A2 Assay for the determination of the hormonal effect of compounds |
| 12/17/2003 | EP1371987A1 Diagnostics and therapeutics for diseases associated with somatostatin receptor 2 (SSTR2) |
| 12/17/2003 | EP1371986A1 Diagnosis of Alzheimer's disease based on the hAbeta42:hAbeta40 ratio |
| 12/17/2003 | EP1371985A2 Means and process for detecting and enriching microorganisms |
| 12/17/2003 | EP1371984A1 Chromatographic assay device and method for detecting the presence of an analyte in a sample of whole blood |
| 12/17/2003 | EP1371983A1 Immunoassay, reagent for immunoassay, and production method of the same |
| 12/17/2003 | EP1371982A1 Device and method for measuring alcohol on the breath |
| 12/17/2003 | EP1371981A1 Sample Retention Apparatus |
| 12/17/2003 | EP1371980A2 Assay chamber |
| 12/17/2003 | EP1371979A1 Microwave device for quality tests on strand like materials |
| 12/17/2003 | EP1371978A1 Microwave apparatus for quality evaluation of strand-like materials |
| 12/17/2003 | EP1371977A1 Method for determining the aptitude of a cosmetic or dermatological product at diffusing and/or absorbing light |
| 12/17/2003 | EP1371976A1 Gas detector for the detection of gases in hot and dusty atmospheres |
| 12/17/2003 | EP1371974A1 Apparatus for detecting interaction between biopolymer and ligand and method thereof |
| 12/17/2003 | EP1371729A2 Use of ttf3 ligands for the diagnosis and therapy of cancer |
| 12/17/2003 | EP1371728A1 Gene encoding adseverin |
| 12/17/2003 | EP1371663A1 Thrombin derivatives and process for producing the same, anhydrothrombin derivatives and process for producing the same, platelet agglutination-inducing compositions, method of inducing platelet agglutination, clinical test reagents, clinical test method, thrombosis inhibitors, adsorbent and process |
| 12/17/2003 | EP1371661A1 Variants of the Constitutive Activated of Retinoid acid response receptor (CAR) in its ligand binding domain (LBD) |
| 12/17/2003 | EP1371425A1 Detector |
| 12/17/2003 | EP1371413A1 Micro-array calibration means |
| 12/17/2003 | EP1370875A2 Liver function test |
| 12/17/2003 | EP1370874A2 Methods for determining platelet activity with antiplatelet compositions |
| 12/17/2003 | EP1370873A1 Short turnaround time insulin or c-peptide assay |
| 12/17/2003 | EP1370872A2 Method of detecting amyloid-containing lesions by autofluorescence |
| 12/17/2003 | EP1370871A2 Screening system based on expression of abcg2 half transporter protein |
| 12/17/2003 | EP1370870A2 Diagnostic screens for alzheimer's disease |
| 12/17/2003 | EP1370869A2 Detection and quantification of cripto-1 |
| 12/17/2003 | EP1370868A2 Technique and screening method for detecting reversible protein-protein interactions |
| 12/17/2003 | EP1370867A1 Protein profiling platform |
| 12/17/2003 | EP1370866A2 Method for determining pharmaceutically active substances |
| 12/17/2003 | EP1370865A2 Metabolic phenotyping in therapy with immunosuppressants |
| 12/17/2003 | EP1370864A2 Marker for roscovitine |
| 12/17/2003 | EP1370863A2 Patch-clamping and its use in analysing subcellular features |
| 12/17/2003 | EP1370862A1 Method and device for detecting fumigants in air samples |
| 12/17/2003 | EP1370861A1 Wide-range toc instrument using plasma oxidation |
| 12/17/2003 | EP1370856A2 Device for the examination of fluids |